Antibacterial Dosing in Intensive Care Jason A. RobertsJeffrey Lipman Current Opinion 30 September 2012 Pages: 755 - 773
Chronopharmacokinetics of Ciclosporin and Tacrolimus Massimo BaraldoMario Furlanut Leading Article 30 September 2012 Pages: 775 - 788
Lack of Pharmacokinetic Interaction for ISIS 113715, a 2′-0-Methoxyethyl Modified Antisense Oligonucleotide Targeting Protein Tyrosine Phosphatase 1B Messenger RNA, with Oral Antidiabetic Compounds Metformin, Glipizide or Rosiglitazone Richard S. GearyJoann D. BradleyAndrè A. van Vliet Original Research Article 30 September 2012 Pages: 789 - 801
Population Pharmacokinetics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran, in Atrial Fibrillation Patients Receiving Long-Term Anticoagulation Therapy Sofie BååtheBengt HamrénUlf G. Eriksson Original Research Article 30 September 2012 Pages: 803 - 819
Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects Reza KhosravanBrian A. GrabowskiLaurent Vernillet Original Research Article 30 September 2012 Pages: 821 - 841
Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl Pharmacokinetics Mona DanvishMary KirbyJohn G. Jiang Original Research Article 30 September 2012 Pages: 843 - 850
Parametric and Nonparametric Population Methods Johannes H. ProostDouglas J. Eleveld Correspondence 30 September 2012 Pages: 851 - 852